Primary and Metastatic Spinal Tumors

14 Primary and Metastatic Spinal Tumors


Ankur S. Narain, Fady Y. Hijji, Philip K. Louie, Daniel D. Bohl, and Kern Singh


14.1 Introduction


Primary and metastatic spinal neoplasms represent a series of complex pathologies that range from benign to life threatening. Detection of spinal neoplasms is further hindered by their indolent progression and vague symptomatology. As such, it is important for the practitioner to understand the nuances in examination and radiographic findings that are present in these patients. Furthermore, as these cases are often complex, understanding of the appropriate timing of nonoperative versus operative management is necessary to ensure the best possible clinical outcome.


14.2 Background and Etiology


Metastatic spinal lesions are much more common than primary lesions.


10-30% of new cancer diagnoses have spinal metastases at discovery:


Spine is the most common site of metastatic bone disease.


Affects thoracic spine (68–70%) > lumbosacral spine (16–22%) > cervical spine (8–15%).


14.3 Presentation and Physical Examination Findings (Table 14.1)


Most common clinical presentation is axial back pain (85–96%).


Progressive, nonmechanical, nighttime pain.


Neurological symptoms: radiculopathy or myelopathy:


Changes in fine motor skills.


Gait and balance instability.


Table 14.1 Classic physical examination findings in metastatic spine tumors


























Primary tumors


Physical examination findings


Breast


Fixed, hard, nontender breast mass Nipple retraction


Prostate cancer


Nodularity in the prostate on digital rectal examination


Thyroid cancer


Painless, palpable thyroid


Lung cancer


Cough, hemoptysis


Renal cell carcinoma


Hematuria, flank pain, abdominal mass


Bowel and bladder dysfunction.


Pathologic reflexes.


Pathologic fractures with subsequent kyphosis.


Weight loss.


14.4 Imaging


Plain radiography:


Odontoid, swimmer’s, and upright views of the entire spine.


Assesses spinal alignment, stability, presence of metastatic lesions, and presence of compression fractures.


Identifies osteolytic and osteoblastic lesions:


Osteolytic: areas of severe bone loss due to excess osteoclast activity, appears as area of radiolucency.


Osteoblastic: areas of excess bone formation due to osteoblast activity, appears as areas of radiodensity.


“Winking owl” sign: lysis of pedicular cortical bone (high sensitivity).


Osseous lesions often not visible on plain radiographs until destruction of greater than 50% of the vertebral body has occurred.


Computed tomography (CT):


Useful for surgical planning and visualization of bone destruction.


Myelography to evaluate for impingement.


Imaging of the chest, abdomen, and pelvis is required for staging.


Poor overall sensitivity (66%).


Magnetic resonance imaging (MRI) ± gadolinium contrast:


T1, T2, and short tau inversion recovery (STIR) weighted images (98.7% sensitivity).


Pedicular involvement, edematous regions with defined borders, noncontiguous involvement are common findings.


Contrast aids in the evaluation of soft tissue, epidural space, and spinal cord.


Bone scintigraphy: technetium-99m:


Shows increased uptake in regions of neoplastic involvement.


Low sensitivity for differentiating metastatic disease from osteoporotic compression fractures, infection, or degenerative changes.


14.5 Diagnosis and Staging


CT-guided biopsy:


Gold standard for tissue analysis:


76% sensitivity for sclerotic lesions; 93% sensitivity for lytic lesions.


Percutaneous approach preferred; open approach may be utilized when percutaneous biopsy is negative but concern for tumor burden remains high.


If the lesion is metastatic, biopsy of primary disease site is preferred.


Staging:


Weinstein–Boriani–Biagini system (Fig. 14.1):



Three-dimensional description of tumor invasion:


Twelve pielike zones rotating in a clockwise fashion starting at the spinous process.


Notes involvement of different vertebral layers: extraosseous soft tissue (A), superficial intraosseous (B), deep intraosseous (C), extradural extraosseous (D), intradural extraosseous (E).


Specifies the involved spinal segment.


14.6 Primary Spinal Tumors (Figs. 14.2, 14.3, Tables 14.214.5)


14.6.1 Metastatic Spinal Tumors (Fig. 14.4)


Background and etiology:


Highest incidence between ages of 40 and 60 years.


Affects males more often than females.


Most common metastatic primary neoplasms:


Breast cancer.


Lung cancer.


Thyroid cancer.


Prostate cancer.


Renal cell carcinoma (RCC).


Can spread via primary neoplasms by hematogenous, direct, or cerebrospinal fluid (CSF) extension:



Hematogenous extension can affect multiple levels via Baton’s venous plexus.


Most mechanistic evidence points toward tumor cell disassociation from a primary mass, penetration of the surrounding extracellular matrix, travel through lymphatic or blood vessels, and seeding of a distant site.


Lesions often located in one of three compartments:


Extradural: most common.


Intradural–extramedullary.


Intramedullary.


Presentation:


Similar to primary neoplasms:


Pain (83–95%).


Constitutional symptoms.


Mar 29, 2020 | Posted by in ORTHOPEDIC | Comments Off on Primary and Metastatic Spinal Tumors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access